Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Danielle Cuthbert & Brady Lee Stein. (2019) Polycythemia Vera-Associated Complications: Pathogenesis, Clinical Manifestations, And Effects On Outcomes. Journal of Blood Medicine 10, pages 359-371.
Read now
Read now
Marina Kremyanskaya, John Mascarenhas & Ronald Hoffman. (2015) Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera. Expert Opinion on Pharmacotherapy 16:8, pages 1185-1194.
Read now
Read now
Articles from other publishers (52)
Carlo Pescia, Gianluca Lopez, Daniele Cattaneo, Cristina Bucelli, Umberto Gianelli & Alessandra Iurlo. (2024) The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective. Leukemia Research 136, pages 107420.
Crossref
Crossref
Evan M. Braunstein, Eddie Imada, Sergiu Pasca, Shiyu Wang, Hang Chen, Camille Alba, Dan N. Hupalo, Matthew Wilkerson, Clifton L. Dalgard, Jack Ghannam, Yujia Liu, Luigi Marchionni, Alison Moliterno, Christopher S. Hourigan & Lukasz P. Gondek. (2022) Recurrent germline variant in ATM associated with familial myeloproliferative neoplasms. Leukemia 37:3, pages 627-635.
Crossref
Crossref
Douglas Tremblay, Adam Winters, Joan D. Beckman, Leonard Naymagon, Rahul Patel, John Mascarenhas & Thomas D. Schiano. (2022) Splanchnic vein thrombosis associated with myeloproliferative neoplasms. Thrombosis Research 218, pages 8-16.
Crossref
Crossref
Marta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, Natalia Curto-Garcia, Parvis Sadjadian, Lee Yung Shih, Timothy Devos, Dorota Krochmalczyk, Serena Galli, Maria Bieniaszewska, Ilona Seferynska, Mary Frances McMullin, Anna Armatys, Adrianna Spalek, Joanna Waclaw, Mihnea Zdrenghea, Laurence Legros, François Girodon, Krzysztof Lewandowski, Anna Angona Figueras, Jan Samuelsson, Aitor Abuin Blanco, Pascale Cony-Makhoul, Angela Collins, Chloé James, Rajko Kusec, Marie Lauermannova, Maria Sol Noya, Malgorzata Skowronek, Lukasz Szukalski, Anna Szmigielska-Kaplon, Marielle Wondergem, Iryna Dudchenko, Joanna Gora Tybor, Kamel Laribi, Anna Kulikowska de Nalecz, Jean-Loup Demory, Katell Le Du, Sonja Zweegman, Carlos Besses Raebel, Radek Skoda, Stéphane Giraudier, Martin Griesshammer, Claire N. Harrison & Jean-Christophe Ianotto. (2022) Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs. Blood Advances 6:17, pages 5171-5183.
Crossref
Crossref
Kristin A. Shimano, Victoria Vanderpoel, Hannah Stone, Linda Resar & Nicole Kucine. (2022) Clinical features associated with thrombotic events in children with myeloproliferative neoplasms. American Journal of Hematology 97:9.
Crossref
Crossref
Yoko Edahiro, Kohshi Ohishi, Akihiko Gotoh, Katsuto Takenaka, Hirohiko Shibayama, Takayuki Shimizu, Kensuke Usuki, Kazuya Shimoda, Masafumi Ito, Scott A. VanWart, Oleh Zagrijtschuk, Albert Qin, Hiroaki Kawase, Narihisa Miyachi, Toshiaki Sato, Norio Komatsu & Keita Kirito. (2022) Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study. International Journal of Hematology 116:2, pages 215-227.
Crossref
Crossref
Rodothea Amerikanou, Jonathan Lambert & Samah Alimam. (2022) Myeloproliferative neoplasms in adolescents and young adults. Best Practice & Research Clinical Haematology 35:2, pages 101374.
Crossref
Crossref
Emanuela Sant'Antonio, Oscar Borsani, Chiara Camerini, Cirino Botta, Marco Santoro, Alessandro Allegra & Sergio Siragusa. (2022) Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy. Blood Reviews 52, pages 100903.
Crossref
Crossref
Alison R. Moliterno & Evan M. Braunstein. 2022. Cellular and Molecular Aspects of Myeloproliferative Neoplasms – Part B. Cellular and Molecular Aspects of Myeloproliferative Neoplasms – Part B
1
24
.
Julian Baumeister, Nicolas Chatain, Alexandros Marios Sofias, Twan Lammers & Steffen Koschmieder. (2021) Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives. Cells 10:12, pages 3551.
Crossref
Crossref
Wafik G. Sedhom & Brady Lee Stein. (2021) Anticoagulation for Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: The Drug and the Duration. Hemato 2:2, pages 255-263.
Crossref
Crossref
Alison R. Moliterno, Yelena Z. Ginzburg & Ronald Hoffman. (2021) Clinical insights into the origins of thrombosis in myeloproliferative neoplasms. Blood 137:9, pages 1145-1153.
Crossref
Crossref
David M. Ross, Jeffrey J. Babon, Denis Tvorogov & Daniel Thomas. (2021) Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications. Haematologica 106:5, pages 1244-1253.
Crossref
Crossref
Alison R. Moliterno & Hannah Kaizer. (2020) Applied genomics in MPN presentation. Hematology 2020:1, pages 434-439.
Crossref
Crossref
Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-DulphyBarbara MoraEmmanuelle VergerNabih Maslah, Aurelie PlessierPierre-Emmanuel Rautou, Isabelle Ollivier-HourmanVictor De LedinghenOdile GoriaChristophe BureauClaudia Siracusa, Dominique Valla, Stephane GiraudierFrancesco Passamonti & Jean-Jacques Kiladjian. (2020) Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Advances 4:15, pages 3708-3715.
Crossref
Crossref
Nicole Kucine. (2020) Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults. Current Hematologic Malignancy Reports 15:2, pages 141-148.
Crossref
Crossref
Alberto Alvarez-Larrán, Arturo Pereira, Marta Magaz, Juan Carlos Hernández-Boluda, Marta Garrote, Beatriz Cuevas, Francisca Ferrer-Marín, M. Teresa Gómez-Casares, Valentín García-Gutiérrez, M. Isabel Mata-Vázquez, Fanny Turon, Virginia Hernandez-Gea, Eduardo Arellano-Rodrigo, Francisco Cervantes & Juan Carlos García-Pagán. (2020) Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis. Annals of Hematology 99:4, pages 791-798.
Crossref
Crossref
Brady L. Stein & Karlyn Martin. (2019) From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms. Hematology 2019:1, pages 397-406.
Crossref
Crossref
Brady L. Stein & Karlyn Martin. (2019) From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms. Blood 134:22, pages 1902-1911.
Crossref
Crossref
Minas P. Economides, Srdan Verstovsek & Naveen Pemmaraju. (2019) Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors. Current Hematologic Malignancy Reports 14:5, pages 460-468.
Crossref
Crossref
Jerry L. Spivak. (2019) How I treat polycythemia vera. Blood 134:4, pages 341-352.
Crossref
Crossref
Jared S. Fowles, Joan How, Maggie J. Allen & Stephen T. Oh. (2019) Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera. Leukemia 33:6, pages 1522-1526.
Crossref
Crossref
Merav Barzilai, Ilya Kirgner, Irit Avivi, Martin Ellis, Najib Dally, Uri Rozovski & Noa Lavi. (2019) Characteristics and outcomes of young adults with Philadelphia‐negative myeloproliferative neoplasms. European Journal of Haematology.
Crossref
Crossref
Laura Anne Habib, Kevin H.M. Kuo, Tony Panzarella, Vikas Gupta & Martina Trinkaus. (2019) Management of Polycythemia Vera: A Survey of Canadian Physician Practice Patterns. Clinical Lymphoma Myeloma and Leukemia 19:1, pages e37-e42.
Crossref
Crossref
Kamya Sankar, Brady L. Stein & Raajit K. Rampal. 2019. Thrombosis and Hemostasis in Cancer. Thrombosis and Hemostasis in Cancer
159
178
.
Michael R. Grunwald, Brady L. Stein, Ralph V. Boccia, Stephen T. Oh, Dilan Paranagama, Shreekant Parasuraman, Philomena Colucci & Ruben Mesa. (2018) Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States. Clinical Lymphoma Myeloma and Leukemia 18:12, pages 788-795.e2.
Crossref
Crossref
Natasha Szuber, Rangit R. Vallapureddy, Domenico Penna, Terra L. Lasho, Christy Finke, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat & Ayalew Tefferi. (2018) Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger. American Journal of Hematology 93:12, pages 1474-1484.
Crossref
Crossref
Joan How, Kathryn M. Trinkaus & Stephen T. Oh. (2018) Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis. British Journal of Haematology 183:2, pages 310-313.
Crossref
Crossref
Ruben Mesa, Ralph V. Boccia, Michael R. Grunwald, Stephen T. Oh, Philomena Colucci, Dilan Paranagama, Shreekant Parasuraman & Brady L. Stein. (2018) Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States. Clinical Lymphoma Myeloma and Leukemia 18:9, pages 590-596.
Crossref
Crossref
Soheila Bagheropur, Ali Ehsanpour, Maryam Tahmasebi Birgani & Najmaldin Saki. (2018) JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms. memo - Magazine of European Medical Oncology 11:2, pages 152-157.
Crossref
Crossref
Imo J. Akpan & Brady Lee Stein. (2018) Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms. Current Hematologic Malignancy Reports 13:3, pages 183-190.
Crossref
Crossref
Jerry L. Spivak. (2018) Polycythemia Vera. Current Treatment Options in Oncology 19:2.
Crossref
Crossref
Marina Kremyanskaya, Vesna Najfeld, John Mascarenhas & Ronald Hoffman. 2018. Hematology. Hematology
1071
1105
.
Prajwal Boddu, Lucia Masarova, Srdan Verstovsek, Paolo Strati, Hagop Kantarjian, Jorge Cortes, Zeev Estrov, Sherry Pierce & Naveen Pemmaraju. (2017) Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms. Annals of Hematology 97:1, pages 109-121.
Crossref
Crossref
Elina A. M. Hirvonen, Esa Pitkänen, Kari Hemminki, Lauri A. Aaltonen & Outi Kilpivaara. (2017) Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera. Human Genomics 11:1.
Crossref
Crossref
Jeffrey Patterson-Fortin & Alison R. Moliterno. (2017) Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender. Current Hematologic Malignancy Reports 12:5, pages 424-431.
Crossref
Crossref
Jerry L. Spivak. (2017) Myeloproliferative Neoplasms. New England Journal of Medicine 376:22, pages 2168-2181.
Crossref
Crossref
Joan How, Amy Zhou & Stephen T. Oh. (2016) Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease. Therapeutic Advances in Hematology 8:3, pages 107-118.
Crossref
Crossref
Mihaila Romeo-Gabriel. (2017) A Very Rare Case of Polycythemia Vera Patient Who Developed Other Four Cancers. International Journal of Immunotherapy and Cancer Research, pages 012-014.
Crossref
Crossref
Brandi Reeves & Stephan Moll. 2017. Practical Hemostasis and Thrombosis. Practical Hemostasis and Thrombosis
210
228
.
Dzhariyat Ismailovna Shikhbabaeva, L.B. Polushkina, V.A. Shuvaev, I.S. Martynkevich, S.I. Kapustin, T.B. Zamotina, M.S. Fominykh, V.U. Udal'eva, I.I. Zotova, V.M. Shmeleva, O.A. Smirnova, S.V. Voloshin, S.S. Bessmel'tsev, A.V. Chechetkin & K.M. Abdulkadyrov. (2017) Genetic Markers of Hereditary Thrombophilia and Risk of Thrombotic Complications in Patients with Polycythemia Vera. Clinical oncohematology 10:1, pages 85-92.
Crossref
Crossref
Jerry L Spivak. (2017) Polycythaemia vera and precision medicine: a prescription for the 21st century. The Lancet Oncology 18:1, pages 9-11.
Crossref
Crossref
Jamile M. Shammo & Brady L. Stein. (2016) Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisions. Hematology 2016:1, pages 552-560.
Crossref
Crossref
Aziz Nazha & Aaron T. Gerds. (2016) Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?. The Oncologist 21:4, pages 475-480.
Crossref
Crossref
Brady L. Stein. 2016. Managing Myeloproliferative Neoplasms. Managing Myeloproliferative Neoplasms
172
177
.
Brady L. SteinStephen T. OhDmitriy BerenzonGabriela S. HobbsMarina KremyanskayaRaajit K. RampalCamille N. AbboudKenneth AdlerMark L. HeaneyElias J. JabbourRami S. KomrokjiAlison R. MoliternoEllen K. RitchieLawrence RiceJohn MascarenhasRonald Hoffman. (2015)
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of
JAK2 V617F
. Journal of Clinical Oncology 33:33, pages 3953-3960.
Crossref
Crossref
S Cerquozzi & A Tefferi. (2015) Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer Journal 5:11, pages e366-e366.
Crossref
Crossref
Lorenzo Falchi, Kate J. Newberry & Srdan Verstovsek. (2015) New Therapeutic Approaches in Polycythemia Vera. Clinical Lymphoma Myeloma and Leukemia 15, pages S27-S33.
Crossref
Crossref
Brady L. Stein, Alison R. Moliterno & Ramón V. Tiu. (2014) Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options. Annals of Hematology 93:12, pages 1965-1976.
Crossref
Crossref
Federico Lussana, Alessandra Carobbio, Maria L. Randi, Chiara Elena, Elisa Rumi, Guido Finazzi, Irene Bertozzi, Lisa Pieri, Marco Ruggeri, Francesca Palandri, Nicola Polverelli, Elena Elli, Alessia Tieghi, Alessandra Iurlo, Marco Ruella, Mario Cazzola, Alessandro Rambaldi, Alessandro M. Vannucchi & Tiziano Barbui. (2014) A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera. British Journal of Haematology 167:4, pages 541-546.
Crossref
Crossref
Giada Rotunno, Carmela Mannarelli, Paola Guglielmelli, Annalisa Pacilli, Alessandro Pancrazzi, Lisa Pieri, Tiziana Fanelli, Alberto Bosi & Alessandro M. Vannucchi. (2014) Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. Blood 123:10, pages 1552-1555.
Crossref
Crossref
Mallika Sekhar, Kathryn McVinnie & Andrew K. Burroughs. (2013) Splanchnic vein thrombosis in myeloproliferative neoplasms. British Journal of Haematology 162:6, pages 730-747.
Crossref
Crossref